Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-23-296691
Filing Date
2023-12-15
Accepted
2023-12-15 16:32:34
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d866431ds3.htm S-3 187339
2 EX-5.1 d866431dex51.htm EX-5.1 13228
3 EX-23.1 d866431dex231.htm EX-23.1 1302
4 EX-FILING FEES d866431dexfilingfees.htm EX-FILING FEES 20913
5 GRAPHIC g866431g1214053516767.jpg GRAPHIC 3252
6 GRAPHIC g866431g1214053516949.jpg GRAPHIC 1414
7 GRAPHIC g866431g13u34.jpg GRAPHIC 47918
  Complete submission text file 0001193125-23-296691.txt   296696
Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Filer) CIK: 0001796280 (see all company filings)

EIN.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-276077 | Film No.: 231490849
SIC: 2834 Pharmaceutical Preparations